The price of innovation: new estimates of drug development costs.
暂无分享,去创建一个
[1] Andrew A. Signore,et al. Pharmaceutical Industry Profile , 2005 .
[2] F. Scherer,et al. The link between gross profitability and pharmaceutical R&D spending. , 2001, Health affairs.
[3] J. DiMasi. New drug development in the United States from 1963 to 1999 , 2001, Clinical pharmacology and therapeutics.
[4] J. DiMasi,et al. Risks in new drug development: Approval success rates for investigational drugs , 2001, Clinical pharmacology and therapeutics.
[5] J. DiMasi,et al. New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms , 2000 .
[6] J M Reichert,et al. New biopharmaceuticals in the USA: trends in development and marketing approvals 1995-1999. , 2000, Trends in biotechnology.
[7] J. DiMasi,et al. Measuring the Pace of New Drug Development in the User Fee ERA , 2000 .
[8] E. M. Healy,et al. The New Drug Approvals of 1996, 1997, and 1998: Drug Development Trends in the User Fee Era* , 2000 .
[9] J. Wagner,et al. HOW INCREASED COMPETITION FROM GENERIC DRUGS HAS AFFECTED PRICES AND RETURNS IN THE PHARMACEUTICAL INDUSTRY , 1998 .
[10] Peck Cc. Drug development: improving the process. , 1997, Food and drug law journal.
[11] Drug development: improving the process. , 1997, Food and drug law journal.
[12] R. Helms. Competitive Strategies in the Pharmaceutical Industry , 1996 .
[13] Henry G. Grabowski,et al. R&d Costs, Innovative Output and Firm Size in the Pharmaceutical Industry , 1995 .
[14] Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry. , 1995, PharmacoEconomics.
[15] E. Broshy,et al. The Contribution of Pharmaceutical Companies: What's at Stake for America , 1994, Annals of the New York Academy of Sciences.
[16] H. Grabowski,et al. Returns to R&D on new drug introductions in the 1980s. , 1994, Journal of health economics.
[17] Associates Ibbotson,et al. Stocks, bonds, bills, and inflation yearbook , 1993 .
[18] L Lasagna,et al. Cost of innovation in the pharmaceutical industry. , 1991, Journal of health economics.
[19] Henry G. Grabowski,et al. A New Look at the Returns and Risks to Pharmaceutical R&D , 1990 .
[20] Robert I. Chien. Issues in pharmaceutical economics , 1979 .
[21] Intangible Capital and Rates of Return , 1977 .
[22] David Belk,et al. The Pharmaceutical Industry , 1965, Nature.